Semaglutide 5mg

1 Vial Semaglutide 5mg lyophilized powder Semaglutide Clinical data Pronunciation /sɛmˈæɡlʊtaɪd/ sem-AG-luu-tyde or /ˌsɛməˈɡluːtaɪd/ SEM-ə-GLOO-tyde AHFS/Drugs.com Monograph MedlinePlus a618008 License data EU EMA: by INN US DailyMed: Semaglutide Pregnancycategory AU: D[1][2] Routes ofadministration Subcutaneous, oral ATC code A10BJ06 (WHO) Pharmacokinetic data Bioavailability 89% Metabolism Proteolysis Elimination half-life 7 days Duration of action 63.6 h Excretion Urine and feces Identifiers CAS Number 910463-68-2 PubChem CID 56843331 DrugBank DB13928 ChemSpider 34981134 UNII 53AXN4NNHX KEGG D10025 ChEBI CHEBI:167574 ECHA InfoCard 100.219.541  Chemical and physical data Formula C187H291N45O59 Molar mass 4113.641 g·mol−1 3D model (JSmol) Interactive image **The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**